Clinical trial
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics
NCT06167174 is registered in ClinicalTrials.gov with Chinese SLE Treatment And Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics
- Lead sponsor
- Chinese SLE Treatment And Research Group
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 5, 2023
- Completion date
- December 5, 2028
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.